Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats

Wronski, 1988, Temporal relationship between bone loss and increased bone turnover in ovariectomized rats, Calcif Tissue Int, 43, 179, 10.1007/BF02571317 Kalu, 1991, The ovariectomized rat model of postmenopausal bone loss, Bone Miner, 15, 175, 10.1016/0169-6009(91)90124-I Barlet, 1994, Animal models of post-menopausal osteoporosis, Reprod Nutr Dev, 34, 221, 10.1051/rnd:19940305 Ross, 2003, Interleukin 7 and estrogen-induced bone loss, Trends Endocrinol Metab, 14, 147, 10.1016/S1043-2760(03)00047-X Fernandes, 2003, Protective role of n-3 lipids and soy protein in osteoporosis, Prostaglandins Leukot Essent Fatty Acids, 68, 361, 10.1016/S0952-3278(03)00060-7 Pacifici, 1996, Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis, J Bone Miner Res, 11, 1043, 10.1002/jbmr.5650110802 Evans, 1990, The effects of recombinant human interleukin-1 beta on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone, Biochem Biophys Res Commun, 166, 208, 10.1016/0006-291X(90)91932-I Igarashi, 1994, Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1, Prostaglandins Leukot Essent Fatty Acids, 50, 169, 10.1016/0952-3278(94)90140-6 Kajii, 1999, Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1), Arch Oral Biol, 44, 233, 10.1016/S0003-9969(98)00120-4 Watkins, 2000, Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats, J Nutr, 130, 2274, 10.1093/jn/130.9.2274 Zeitlin, 2003, Effects of long-term administration of n-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice, J Cell Biochem, 90, 347, 10.1002/jcb.10620 Li, 1999, Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids, J Bone Miner Res, 14, 1153, 10.1359/jbmr.1999.14.7.1153 Watkins, 2003, Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism, Prostaglandins Leukot Essent Fatty Acids, 68, 387, 10.1016/S0952-3278(03)00063-2 Watkins, 2001, Bioactive fatty acids: role in bone biology and bone cell function, Prog Lipid Res, 40, 125, 10.1016/S0163-7827(00)00016-3 Kelly, 2003, The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats, Br J Nutr, 90, 743, 10.1079/BJN2003951 Weiler, 2002, Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets, J Nutr, 132, 2667, 10.1093/jn/132.9.2667 Sakaguchi, 1994, Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats, Prostaglandins Leukot Essent Fatty Acids, 50, 81, 10.1016/0952-3278(94)90151-1 Watkins, 2005, Protective actions of soy isoflavones and n-3 PUFA on bone mass in ovariectomized rats, J Nutr Biochem, 16, 479, 10.1016/j.jnutbio.2005.01.019 Ammann, 1992, Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry, J Bone Miner Res, 7, 311, 10.1002/jbmr.5650070310 Watkins, 2004, A test of Ockham's razor: implications of conjugated linoleic acid in bone biology, Am J Clin Nutr, 79, 1175S, 10.1093/ajcn/79.6.1175S Igarashi, 2002, Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro, Biochem Pharmacol, 63, 523, 10.1016/S0006-2952(01)00861-9 Darlington, 2001, Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders, Br J Nutr, 85, 251, 10.1079/BJN2000239 Armour, 1999, Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis, J Bone Miner Res, 14, 2137, 10.1359/jbmr.1999.14.12.2137 Priante, 2002, Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid, Clin Sci, 102, 403, 10.1042/cs1020403 Curtis, 2002, Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids, Arthritis Rheum, 46, 1544, 10.1002/art.10305 Weiss, 2005, Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study, Am J Clin Nutr, 81, 934, 10.1093/ajcn/81.4.934 van Papendorp, 1995, Biochemical profile of osteoporotic patients on essential fatty acid supplementation, Nutr Res, 15, 325, 10.1016/0271-5317(95)00002-X Kruger, 1998, Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis, Aging, 10, 385 Bassey, 2000, Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone, Br J Nutr, 83, 629, 10.1017/S0007114500000805